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ABSTRACT
Engaging recent social science work examining the truth making
claims of science and biomedicine, this paper explores how biology
is being localised in Brazilian cancer genetics. It draws from
ethnographic ﬁeldwork in urban regions of southern Brazil working
with and alongside patients, families and practitioners in cancer
genetic clinics. It examines how different sorts of ‘local biologies’
are articulated in the context of research, clinical practice and
among implicated patient communities and the way these can
‘recursively’ move across different spheres and scales of social
action to extend and transform the meaning of the biological. It
shows how the mattering of the biological in Brazilian cancer
genetics is fundamentally informed by questions of inequity and
care, even while multiple local biologies may obscure rather than
reveal the biopolitics of cancer. In an era of epigenetics this raises
new opportunities and challenges for anthropological analysis as
intervention.
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The way that the truth making claims of science, including those related to genomics, are
reproduced and sustained, has been widely examined by social scientists drawing on a
range of theoretical approaches from medical anthropology and Science and Technology
Studies (STS)(Taussig 2009; Rapp 2000; Fullwiley 2011; Reardon 2004; Gibbon et al.
2014). From these perspectives genes, genetic knowledge and technologies are ‘co-
produced’ as an ‘assemblage’ of social and biomedical discourses and practices. As the
same time efforts to move beyond the ‘body proper’ (Lock and Farquhar 2007), to ‘trou-
ble, problematise and scrutinise natural categories’ (Lock 2013) and challenge notions of a
universal biology reﬂect long standing interest in medical anthropology with what have
been described as ‘local biologies’. Informed by Margaret Lock’s work on menopause in
Japan this concept has been used to illuminate the contingency and interdependency of
the material and the social and underline the need to examine the embodied experience of
health and illness in speciﬁc local contexts, the cultures of biomedicine and the ways that
the biological and social are increasingly entangled (Lock 2001; Lock and Nguyen 2010).
It is a concept which has gained renewed force and relevance in a post-genomic era in
which the biological seems to be increasingly localised from the ‘ inside out’, with growing
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uncertainty about the stability of ‘the gene’ and the complexity of gene function vis-a-vis
variously deﬁned environments (Lock 2013). It is a central tool in this special issue in con-
sidering the challenges, opportunities and limits of new theoretical approaches for making
visible, engaging and understanding the signiﬁcance of diverse bodies and biologies.
This paper draws from these different approaches to examining the (changing) onto-
logical status of the biological to illustrate how a variety of local biologies are articulated,
manifested and intersect in cancer genetic research and medical practice in southern
Brazil. It is based on 18 months ethnographic ﬁeldwork working with and alongside
patients, families, scientists and practitioners in three urban cancer genetic clinics.1 It out-
lines how in an era of transnational globalisation of genomics the localisation of the bio-
logical in Brazilian cancer genetics is taking place across different domains of social action
and how this involves a variety of different assemblages that displaces some bodies, biolo-
gies or materialities, whilst cohering the interconnections between others. It reveals the
mattering of the biological in Brazilian cancer genetics to be fundamentally informed by
questions of inequity and care. At the same time these multiple but ‘less than many’ (Mol
2014, 2003) biologies reﬂect not only difference or disjuncture but cross cutting, clashing
and sometimes generative intersections. In this way the paper illuminates how cancer
genetics in Brazil is not only shaped by an engagement with and articulation of diverse
local biologies but how these move across different spheres and scales of social action to
both extend and/or transform the meaning of the biological. In examining these shifting
and in some cases ‘recursive’ dynamics, the paper engages with work in anthropology
examining how scientiﬁc ‘facts’ associated with reproductive and genomic technologies
are subject to ‘domaining’ (Strathern 1992) or ‘analogic return’ (Franklin 2014), as well as
Hacking’s notion of ‘looping effects’ (2006). The paper outlines how this entanglement of
local biologies operates within and at the intersection of three different arenas of social
practice in Brazilian cancer genetics. This includes scientiﬁc research agendas in which
genetic ancestry and cancer as an increasingly stratiﬁed disease is foregrounded in pursuit
of yet-to-be known cancer risk; the precarious health infrastructure of Brazilian cancer
genetics where the boundary between care and research is thin and marked by inequities
as well as limited resources and ﬁnally the embodied experience of cancer risk in which
socio-historic speciﬁc articulations of bodily vulnerability are being contemporarily
reconﬁgured.
Cancer genetics in Brazil: unknown risk and research in pursuit of local
biology
Brazilian cancer genetics emerged in early 2000s at the meeting points between a growing
public health concern with rising rates of cancer incidence and mortality and national
and transnational research agendas which constitute cancer as an increasingly differenti-
ated disease. It is an arena of scientiﬁc research and medical practice in Brazil which is
unfolding within a domain of severe resource limitations, with consequences for the
inter-relationship between research and care.
Particularly high recorded rates (equivalent to the US population rates) of breast and
prostate cancer, across the southern regions of Brazil, have long been noted by the
National Cancer Institute (INCA 2009). Constituted as part of the effort to address what
is a growing public health concern, the hub of an emerging ﬁeld of cancer genetics has
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developed linked to large, mostly public health or university hospital research institutes in
these same regions. Brazilian cancer genetics is not however currently integrated into the
public health care system or SUS and is almost entirely reliant on research funds and col-
laborations. The often ﬂuid boundary between clinical care and research objectives is a
feature of the ‘bio-clinical collectives’ (Bourret 2005) that characterise cancer genetics
more generally (see also Hallowell et al. 2009). Nevertheless this has speciﬁc consequences
when public health services are fractured and uneven as they are in Brazil. As a result
patients and families are recruited into programmes of care via research protocols, linked
to high proﬁle areas of inquiry such as BRCA genes or research on ‘rare’ cancer syn-
dromes. Eligibility for participation in research (and the care this promises) are therefore
highly contingent on the availability of research funds. This can leave many patients and
families waiting for months or sometimes years for a conclusive test result. They are as a
result stratiﬁed ‘patients-in-waiting’ (Timmermans and Buchbinder 2010), dependent on
the availability of resources to pursue genetic testing via research or sometimes left not
knowing the clinical relevance of an identiﬁed biomarker or mutation. As I examine in
the latter part of the paper, this is a terrain of uncertainty which has particular consequen-
ces for how patients understand and engage with the ontologies of embodied genetic risk.
Taussig et al. illuminate how the potential of the not-yet-known propels many novel
ﬁelds of development in the life and medical sciences (2013). This includes Brazilian can-
cer genetic research as it unfolds in dialogue with international research in which cancer
is being increasingly biologically diversiﬁed and stratiﬁed and as new genetic variants and
other biomarkers become identiﬁed as potential targets for the promise of personalised
medicine (Lee 2013). This has enabled as yet ‘unknown’ genetic risk of cancer to be
deﬁned as an object of research in Brazil where a particular focus on genetic ancestry and
population difference is foregrounded in efforts to address and intervene on rising yet
regionally differentiated national cancer rates. It is a focus which is reﬂected in the
National Brazilian Hereditary Cancer Network’s stated goal of ‘needing to know and char-
acterise the particular aspects of our population’ (INCA 2009), providing a further illus-
tration of how genetic risk of cancer in Brazil is situated in terms of a local biology.
Nevertheless the research focus on genetic ancestry is characterised by a dual emphasis
in Brazilian cancer genetics which produces mutable and mobile biologies. On the one
hand there is an emphasis in scientiﬁc publications on regional speciﬁcity associated with
migratory histories, particularly the inﬂux of European migrants to the southern regions
of Brazil in the early nineteenth and twentieth centuries. This has justiﬁed an initial
investment in research focused on identifying the frequency of common well-character-
ised BRCA founder mutations. On the other hand there is an emphasis on national ‘tri-
hybrid’ ancestries, that also demarcate the region as different from the US and European
context (see Gibbon 2016a). This movement between alternately highlighting ‘heterogene-
ity and homogeneity’ has been widely noted by other social scientists examining how pop-
ulation genomics in Brazil and the wider region of Latin America is informed by and
conﬁgures particular ideas of nationhood, identity and race (Wade et al. 2014; Kent, San-
tos and Wade 2014). Santos et al. suggest that a focus on genetic ancestry in Brazilian
pharmacogenomics research has served to underlie the speciﬁcity of both Brazil and the
Latin American region (2015). In a similar way the foregrounding of genetic ancestry in
Brazilian cancer genetics works to articulate the importance of the local biologies that
might be contributing to rising and variable cancer incidence. These are conﬁgured
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however not only in terms of ‘unknown’ risk but also in relation to ‘under-served’ popula-
tions (Gibbon 2015); an emphasis which also reﬂects wider dynamics in the way the glob-
alisation of genomics is being tethered to questions of social justice (Fullwiley and Gibbon
forthcoming).
While inequities are highlighted within the research aims of Brazilian cancer genetic
research, the day to day reality of limited health care resources also directly shape clinical
practices. Stratiﬁed abilities to leverage and access medical interventions inform the ‘onto-
logical choreography’ (Thompson 2005) of clinical practice in Brazilian cancer genetics. In
the clinic particular kinds of risk and bodies are mattered or made material with conse-
quences for the local biologies made possible and reproduced at this interface.
Materialising risk and care in a context of public health inequities: abject and
distributed bodies
An ethnographic excerpt from my ﬁeld notes illuminates how certain materialities, in this
case living with cancer and the stark reality of a lack in public health resources, disrupt
and disturb the preventative promise of cancer genetics.
In a busy morning in the cancer hospital in Rio the normal long queues are forming in the
large waiting room area, where oncology and cancer genetic patients are waiting to be seen,
next to the cramped consulting room area that the cancer geneticists and oncologists must
negotiate between appointments. Many cancer patients are identiﬁable in the waiting areas
clustered around the inadequate seating together with their families. With drips attached to
their arms they are characterised by pale anxious faces and often hairless heads. Several are
clutching notes in plastic bags, or large thick battered folders from which x-ray scans and
other medical images are visible.2 Cancer patients, while noticeable in the hospital grounds,
entrance and waiting areas, were however mostly absent from the cancer genetic clinics. For
the most part patients in these clinics are relatives of those who have had or were being
treated for cancer. However at the end of the morning clinic in Rio a couple in their late ﬁf-
ties squeeze themselves into the small consulting area. The man has a drip entering his nose
and he is pale, thin with a noticeably grey pallor, made even more evident by an absence of
hair and eyebrows characteristic of those being treated for cancer. The woman explains that
the consultant they have been seeing in the hospital referred him to the cancer genetic clinic
because of the family history. It is clear that the geneticist is uncomfortable and reluctant to
fully investigate these aspects when the mostly silent man is clearly so unwell and in the mid-
dle of treatment. The clinician discovers that he is about to go upstairs for a session of radio-
therapy, although the woman states that they are ‘not sure if the equipment is working
today’. After a ﬂeeting discussion of the history of cancer in the family the conversation turns
to the treatment protocol the patient is receiving, with the geneticist asking who is overseeing
the husband’s care in the hospital. This prompts the woman to talk about the long and costly
journeys they frequently have to make from the outskirts of the city on public transport to
get to the hospital, because there is currently no reliable hospital transport service. It is a
short consultation with the normal focus on who is at risk in the family and who could be
entered into a cancer genetic research protocol or be eligible as a result for genetic testing dis-
placed by the everyday reality of managing cancer treatment and lived bodily manifestation
of its consequences. When the couple exit the geneticist is exasperated at the referral, railing
at the ignorance of some of the oncology team in sending a cancer patient who is clearly not
well to the genetic clinic at this stage in their treatment.
The presence of what might be seen as the ‘abject’ cancer body in this ethnographic
illustration serves to inadvertently expose for both the geneticist and patients the
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shortcomings of Brazilian cancer genetics in a context of inadequate health care provision.
The prospect of participation in research that may take months if not years to yield a
result of questionable utility is subsumed by the challenges of treatment and care for the
cancer patient. It suggests that the lived and embodied reality of cancer is not easily man-
aged within the space and practice of Brazilian cancer genetics and is sometimes revealed
as inappropriate care. Such inequities also however have consequences for how the biolog-
ical in the cancer genetic clinic is mattered through an assemblage of ‘hidden’ technologies
which work to articulate a local biology in which distributed genetic risk is emphasised.
Social scientists have noted how the practices of the cancer genetic clinics in diverse
locales are widely characterised by attention to not only the health or future cancer risk of
the patient attending the clinic but the past, present and predicted risk of other relatives
and/or future generations (Hallowell 1999; Gibbon 2007). Often the person in the clinic
seeking information does not have cancer themselves or may discover that they may not
be at most genetic risk of the disease now or in the future. This is visibly evident in the
way that risk assessment is calibrated most frequently on the basis of family history made
material and present in the collective attention to the medical family tree (see Gibbon
2002). This is also a signiﬁcant dimension of the practices of clinical cancer genetics in
Brazil which serves to constitute a relational patienthood that situates risk on the basis of
past histories of cancer in the family and for future generations. As a result, despite pain-
ful memories of cancer often ‘haunting’ clinical consultations, the ‘lived cancer body’ is
frequently displaced or made somewhat absent, as the above ethnographic excerpt illus-
trates. Moreover a dependency on research funds and the frequent lack, due to a shortfall
in resources, of routine access to genetic testing make efforts to draw up detailed clinical
family trees the substantive component of clinical routines and practices, further fore-
grounding the relational aspects of genetic risk.
While the family tree is one key dimension of Brazilian cancer genetics other materia-
lites are also central. These not only serve to similarly emphasise the relational aspects of
cancer risk but also reﬂect how inequities in health care shape which bodies have the
potential to matter.
In the mixed public/private hospital in Sao Paulo patient and family case notes would
be visibly marked on the front stamped in red letters SUS or CONVENIO to inform the
practitioner if the patient was a public health patient or if they were part of a private
health insurance scheme. Notes stamped with convenio would travel to and from the con-
sulting space as administrators and practitioners attempted to negotiate with private
insurance providers to establish who within the family would be eligible for or who could
seek additional screening. Whilst securing a genetic test in this way was unlikely,3 addi-
tional screening and monitoring was often possible via negotiations with private insurance
schemes, not only for the individual patient with a convenio but also sometimes for other
related family members. As patients and extended family members waited in the consult-
ing room there would be hasty telephone calls by the clinic’s administrator to establish
who and what could be covered by the insurance provider; an outcome which would often
inform ﬁnal decisions about treatment programmes and screening interventions. With
many patients commenting upon their ‘luck’ at being seen within a leading cancer
research hospital where according to one patient, ‘everything is a blessing’, being able to
access extra screening services for oneself and one’s family in the context of a fractured
system of public health care was seen as an added beneﬁt. In a similar way that producing
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the clinical family tree distributes cancer risk beyond any individual body, negotiations
related to convenios, concerning access to screening and care services, have an equally dis-
placing affect. As a result attention is focused not only on traumatic personal histories of
cancer but also on relations as social obligations and rights, between family members.
Collectively these practices constitute a key part of the clinical routines of Brazilian
cancer genetics, materialising bodies and relational risk at the interface with the ﬁnancial
and resource limits of research and care in speciﬁc ways. The contingencies which are
quite literally mattered in clinical practice centre on the family tree and collective efforts
to gain access through research to genetic testing or rights to basic care such as mammog-
raphy screening on the basis of having a convenio. These practices co-produce a relational
local biology which is directly shaped by the reality of health care inequities. However for
patients cancer risk is made meaningful and present in ways that foreground other bodily
and non bodily materialities, evoking seemingly different local biologies.
Embodying cancer risk: emotion and social relations in the family
For many patients attending cancer genetic clinics in Brazil, genetic mutations were rarely
understood as the sole or sufﬁcient cause of cancer, but were almost always interacting
with other factors. Sometimes a generalised notion of stress, would be implicated. This
was for instance the way that a female middle aged patient from Porto Alegre talked of
how daily stress might enter and act on the body:
‘because you are in that state of ‘pique’ [meaning alertness, anxiety or stress] all day and the
body seems like its not being affected you know but you go about really hyped up and your
cells really hyped up or your blood.. and while you are like this your body is tired, your head
is buzzing and thinking, thinking things it shouldn’t, so I think a lot of it is stress for breast
cancer – stress is a something that makes your antibodies slow. [my emphasis]
However many patients went beyond the discussion of a generalised notion of stress,
talking speciﬁcally about the way that ‘negative’ emotions acted on the body in producing
a risk for and/or causing cancer. Emotions were something that could enter and co-pro-
duce bodies and disease. In part this reﬂects the growing relevance in a contemporary Bra-
zilian context of a psychologically infused notion of the self or ‘psi-self’ (Duarte 2000). But
it also is an expression of an understanding of bodies as porous, co-produced as a conse-
quence of a problematic past or lived relations in the family as well as the intergenera-
tional consequences of suffering or trauma. As the case studies outlined below illustrate
emoc¸~oes have an agentive and mattering consequence on bodies in ways that link the
trauma of familial cancer to poverty, violence, religion, pollution and diet as well as
reﬂecting a high proﬁle media discourse about psychological self-management.
Ana Paula was in her early 40s, she lived in Porto Alegre and worked in a shoe factory
in one of the urban suburbs of the city. As well as having had breast cancer herself, a very
large number of her family had had cancer including her father, a number of sisters and
most recently her teenage daughter who was currently being treated for a rare bone can-
cer. The family were under the care of the oncogenetica team in the hospital and were
waiting the results of blood tests to conﬁrm if a genetic mutation had been identiﬁed in
the family. During our ﬁrst meeting Ana Paula recounted in detail these traumatic experi-
ences of cancer as she had grown up. She recalled the physical horror of those relatives
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who had had debilitating experiences of suffering and in many cases dying of cancer,
pointing out how this had understandably ‘marked’ her greatly. She told me that since
being treated at the public hospital she had always heard that it ‘could be genetic’ adding
‘it could be that different bolts of lightning fell in the same place at the same time’. In fact
elaborating further later in the interview she told me that she always thought that it was
‘emotional’. This was how she put it:
‘I am always hearing interviews on the television with doctors about where breast cancer
comes from? It comes from continuous hurt, from anger I’m always hearing this. All the
time I was having treatment I heard this that it comes from genetic inheritance so it could be
emotional factors ..and in my family too I’m beginning to think that it’s this.. to be certain
that it’s the two together because our head co-ordinates our body. I think that feelings are
part of our daily existence and you don’t know but one day you say something bad and you
hurt someone or you are hurt. These are things that you can’t predict. I think that it’s this
because my husband left me when I was unwell and then I started to hold my sadness, my
hurt and then the breast cancer developed. I did all my treatment alone and ﬁnally my cancer
was sleeping. But I was deceived by someone else I was living with and the cancer returned in
another place’.
For Ana Paula genetic inheritance is inseparable from the inter-relational and embod-
ied effect of emotions on the body and the self from others. At the same time this seems
in part also informed by the clinical information she has been given about genetic risk
and a media discourse about psychological well-being.
Luiza Maria expressed similar sentiments about the cause of cancer as related to her
family relationships. She was 45 years old and worked as a legal secretary in Sao Paulo
and had been treated for breast cancer twice ﬁrst in her early 30s and again more recently.
There had been other cases of cancer in her distant family and she was awaiting the result
of a genetic test on the BRCA genes. She talked openly about how she had found the sur-
gery and treatment she had received as ‘mutilating’ and how this had caused psychological
problems in her marriage of ten years. This is what she said in response to a question
about what she thought the ‘causes’ of cancer were.
I think cancer can occur because of emotional problems. I lost a loved one in the house that I
was building in an accident and this really affected me [isso me marcou muito]. I am a person
who somatises [using the verb somatizar] problems. Unfortunately, I’m very connected to
family. I had a brother who at the same time got involved in drugs, so I was very sad about
all this. Soon after my husband lost his job, my father died all very close together. So I think
that it’s all because of this, because I’m a very emotional person, because I always go behind
problems, I worry about them too much. All this ‘somatisation’, I think it just left me really
sad without a way to resolve my problems.
Liliane was in her late 50s and had now retired after being a teacher for many years. She
had had a traumatic and troubling history of cancer in the family which she recounted in
great detail at the start of our meeting telling me how her daughter, sister and nieces had
all had cancer. She herself had a few years ago undergone treatment for colon cancer and
like other members of the family had been identiﬁed as a carrier of a particular founder
mutation R337, linked in Brazil to an inherited cancer syndrome known as Li-fraumeni.
While she acknowledged this as a factor, like other patients, she also foregrounded the
agentive consequences of emotional dynamics in the family. As the exchanges outlined
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below illustrate for Lilliane the meaning of ‘predisposition’ was a complex mesh of social
and psychological factors.
Liliane: Like she said [the geneticist] we have the predisposition. Mine in particular, not like
my daughter who was a baby and came with the genetic factors and perhaps others in the
family too. But this niece that died of adrenocortical cancer, she had a problem in the house,
she lived with conﬂict even when she had the disease. And my other niece who had breast
cancer she had a problem too as a baby. My sister married, she had a child, but the father
was an alcoholic,… so my sister really had a history and I think my niece suffered too. Later
she remarried and they had a good life, he was like a father to me in fact, but he died and it
was like losing my father.. So I think that I have a history.
Sahra: Do you think that this history is more important than other risk factors for cancer?
Liliane: I think that it interferes (mexe).. messes with a person. I think that in the end it left
something inside. But in that period when I discovered the cancer, nearly 2 years ago..I was
experiencing strong emotional problems. I was hurt (estava magoada).. so when I discovered
I was very sad, things started happening which messed with me (mexendo conmigo). Even
when I went to the doctor and he said to me ‘You don’t have any reason to have this, a
healthy person, you don’t smoke, you don’t drink, you exercise.’ He even joked ‘what frog
did you swallow’ ? (Que sapo voce engoliu)4
So I think this increases the chance a little more. Given what we are hearing people say, what
we read on the internet, at times you read in a book. I’ve read books that say emotional
aspects are everything. Emotions interfere with the entire body I think.
The emphasis on the embodied and mattering consequences of suffering, hurt, sadness
and negative emotions in these narratives refute the notion that for these patients genetic
mutations provide the necessary explanatory parameters for cancer in the family. Signiﬁ-
cantly even when genetic risk is concretised, as it had been for Lilliane following a positive
test result, there is still an emphasis on the interaction between the biological and particu-
lar forms of sociality and social relations in rendering meaningful cancer as an illness
experience or in terms of its embodied danger.
Entangled local biologies
These apparently ‘de-molecularised’ readings of cancer and bodily risk (see Gibbon
2016b) resonate with well recognised ‘folk’ understandings of the body in Brazil and Latin
America where, as Roberts points out, the ‘reciprocal malleability of bodies and environ-
ments’ has long been evident (2015). Social science work in Brazil illustrates the variety of
ways the sick body is often perceived as being subject to and produced through exogenous
inﬂuences, including illnesses such as nervismo in Brazil (Duarte 1986) or the embodied
consequences of strong emotions for health (Rebhun 1994).5 Recent research highlights
how ideas about porous bodies also resonate in the context of biomedical interventions
such as IVF, hormones and cosmetic surgery in different regions of South America (Rob-
erts 2010; Edmonds 2011; see also Sanabria and Lowy 2016; see also Rohden 2001). Emilia
Sanabria’s work examining hormonal menstrual suppression in Bahia in the north east of
Brazil demonstrates how humourally inﬂected notions of blood are an expression of the
body not as ﬁxed or deﬁned by rigid boundaries but as contingent and subject to ﬂow and
8 S. GIBBON
D
ow
nl
oa
de
d 
by
 [U
CL
 L
ibr
ary
 Se
rv
ice
s] 
at 
04
:14
 10
 A
ug
us
t 2
01
7 
transmutability (2016). But as the work of Sanabria (2016) and Edmonds (2011) illumi-
nates, bodily plasticity in the context of hormone treatment or cosmetic surgery ﬁnds
expression in Brazil in dialogue with contemporary biomedical interventions, not outside
or beyond them.
In a similar way I would argue biomedical discourses about genetic risk and patients’
rendering of embodied risk becomes part of an expression of diverse local biologies in
which cancer, emotions and the vulnerable body are co-constituted. Clinical dynamics
aimed at identifying high risk families are often intensely focused with medical family his-
tory or with negotiating collective, yet ultimately differentiated, access to care in ways that
necessarily shape past understanding of and contemporary lived social relations in the
family. As histories of cancer in the family are re-lived and familial rights and obligations
aligned in the negotiations surrounding access to care, testing and screening, a certain
licence is afforded to these broader understandings of the mutable body as informed by
emotional relations between kin. Notable here is Ana Paula’s response that the cause of
her cancer is ‘emotional’ after hearing in the clinic that her cancer could be linked to
genetic factors or the way that Luiza Maria equates herself as a person who ‘somatises’ ill-
ness because she is ‘unfortunately connected to family’. Similarly, Lilliane’s understanding
of ‘pre-disposition’ reﬂects difﬁcult family relations and stands in contrast to other
affected relatives, such as the children with cancer in her family, who only had a ‘genetic’
risk. These illustrative examples suggest that between clinical communication and
patients’ embodied understanding of genetic risk there is a ‘looping effect’ (Hacking 2006)
or ‘recursive return’ (Franklin 2014). For the patients I met this re-inforces the bodily rele-
vance of problematic emotional difﬁculties in interpersonal relations which are then read
back onto the signiﬁcance of potential genetic risk that is emphasised by clinicians.
Importantly whilst this movement coheres the reality of genetic risk for patients, for
many practitioners its presence represented something of a disjuncture or a ‘clash’. For
example, a number suggested, that the agency given to negative emotions by patients erro-
neously sustained familial blame and guilt, instead of seeing cancer in the family as
‘nobody’s fault’, as one doctor put it.
A further illustration of the ‘looping’ intersections between different localisations of the
biological in Brazilian cancer genetics is also made evident in examining how the rele-
vance of genetic ancestry was sometimes incorporated and woven through patients’
understanding of embodied risk for cancer. While discussions about genetic ancestry
were most explicit in the context of international research publications and collaborations,
my research suggests they also ﬁnd defuse and subtle articulation within the clinical con-
texts and in interaction with patients (Gibbon 2016a). This can further entangle different
local biologies as patients conﬁgure biomedical information about cancer risk and ances-
try alongside a sense of embodied vulnerability.
An explicit discussion of genetic ancestry was not frequent in the clinical consultations
I observed. More usual were implicit statements by a clinical geneticist about the fact that
an identiﬁed genetic mutation might be ‘more common in the south’. Sometimes this
would be associated with the history of migration to certain parts of Brazil, particularly
the arrival of the Portuguese or European populations in the nineteenth and twentieth
centuries. These ﬂeeting comments could however precipitate a more reﬂective discussion
from patients and their relatives about regional identity or family origins/ancestry. As the
case study outlined below illuminates an awareness of the relevance of genetic ancestry to
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clinical research might not only conﬁrm cancer risk as relationally constituted across gen-
erations, but serve to evoke the wider context of gendered roles in the family and the agen-
tive role of emotional suffering.
Marcia was in her early ﬁfties and worked as a paediatric nurse in a public hospital in
Porto Alegre. She had had cancer a number of years previously and was told by the genet-
icist that given the number of cases of breast and ovarian cancer in the family that there
was a high risk of identifying a genetic mutation in the family. She and other members of
her family despite being involved in research protocols for a number of years still had not
received conﬁrmation that a deleterious mutation had been identiﬁed. Marcia did not hes-
itate to tell me about how she saw the complexity of cancer. In her eloquent and thought-
ful responses to my queries she made it clear that genetic factors were always in
interaction with a range of other aspects of individual, gendered and more importantly
collectively lived lives. She put it like this.
Cancer has various origins. There is the genetic component, environmental factors, ciga-
rettes, alcohol, pollution, we know these things exist. But along with this I think there exists a
personal aspect in some way that makes you more vulnerable to cancer in certain parts of
your body. So in our family we have large numbers of women with breast cancer. Why is it
always breast cancer? Of course we have the genetic factor but why always breast cancer ? All
the women in my family are from large families, women who really had to struggle to keep
their families, their husbands and their children. So I really think there exists this mental
component that ends up in the most vulnerable organs.
In another part of our interview she mentioned this again talking about how her grand-
parents came from Germany during the period of widespread migration to the south and
interior part of the southern state of Rio Grande do Sul and how this might contribute to
cancer risk in the family. In the dialogue that followed this was further clariﬁed.
Sahra: Do you really think that this is a risk factor for having cancer ?
Marcia: Yes with respect to the genetic question..I remember doing that tree with Dr H and
we saw all those generations, so this history is present in our family. Perhaps as it passed
between generations the genetic factor changed some things and of course this is related to
the emotional question too.
Sahra: I’m interested to know more how you think cancer is associated with being German or
a certain emotional state?
Marcia: Not only with the emotional question but the female question. The women were very
subjugated, only looking after the children, big families, hard work, always giving too much,
so they lived in this situation of what we could call emotional poverty. So I think this cultural
question interacts, has interacted and is interacting with our genetic predisposition so that
it’s possible this question of German culture will mean other future generations with breast
cancer..who are these women with breast cancer in the south? They are women originally
from Germany, Italy, Brazilian mothers with this ancestry. But I think this question of female
culture is important even though in recent decades they are more liberated we could say..in
the south we say we are more advanced but its really very provincial, we are still very rigid
here in certain ways.
Sahra: So you think that this cultural factor inﬂuences in a certain way?
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Marcia: I think it inﬂuences Sahra in the way I already mentioned. In the moment when we
are immunologically more vulnerable we develop a cancer. Even though it’s been proved that
if you have the gene you get breast cancer. But there are people now who work in science
who are turning to the social and cultural aspects. Because these cultural and emotional ques-
tions that are provoked by our thoughts, cause chemical reactions, molecular, neurological
changes inside our bodies. They translate into something concrete. Our thoughts are not just
our thoughts they occur inside our body as well.
Marcia’s narrative not only highlights the difﬁculty of disaggregating the social and the
biological in the way that patients I encountered understand and make sense of cancer
risk, but how speciﬁc elements of a biomedical discourse concerning genetic ancestry dif-
fusely inform a sense of embodied vulnerability. The traumas experienced by Marcia’s
family in their migratory experiences indelibly marks gendered bodies and is transformed
‘into something concrete’ that is then passed on down the generations as cancer risk.
While the discussion of ‘female culture’ evokes a wider politics of gender relations, this is
nonetheless mostly framed by Marcia in terms of ‘emotional poverty’ where ‘thoughts’
can literally matter the biological. Importantly we also see in this example not only how
clinical idioms ‘loop’ back to inform patients’ understanding of embodied risk, but how
the latter move recursively forward. Marcia’s reading of bodily risk and danger powerfully
evokes and resonates with an emerging biomedical narrative about epigenetics in which
past traumas during ‘critical windows’ of development are increasingly thought to be rele-
vant to addressing and understanding a range of disease pathways (Panofsky and Land-
ecker 2013). Notwithstanding Marcia’s own awareness of the relevance of an emerging
science of epigenetics, as herself a health professional, her comments point to another
dimension of what are likely to be numerous new loops and returns in the entangled local
biologies of cancer genetics, in Brazil, as elsewhere. As the interactions between genes and
environments gain traction across diverse terrains of cancer research and become embed-
ded into clinical routines it will be important to examine how different understandings of
the biological and disease risk (both biomedical and so called ‘folk’ models) are mutually
re-shaped.
Conclusion
Drawing on ethnographic research in the context of clinical cancer genetics in Brazil this
paper has examined how practitioners, researchers and patients engage with the biological
ontologies of cancer risk. Informed by longstanding and on-going engagement with local-
ising the body and the biological in medical anthropology, it has critically considered how
particular ‘local biologies’ are reproduced across and within different social terrains
encompassed by Brazilian cancer genetics. This includes research efforts to address
national public health priorities through transnational collaborations; the contingencies
of clinical practice and in the ways embodied risk is understood and constituted by
patients and families. Beyond simply highlighting diversity the paper has illuminated how
the biologies produced within these social contexts intersect, sometimes clash, but also
loop back to shape a range of narrativised risk discourses and practices encompassed by
and conﬁgured within Brazilian cancer genetics. It has underlined the extent to which
health care inequalities are deeply implicated in the way that bodies and different articula-
tions of the biological are being conﬁgured.
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Speciﬁc kinds of local biologies are sustained in scientiﬁc research related to genetic
ancestry in Brazil. This is mobilised in pursuit of national and transnational research col-
laborations aimed at characterising ‘unknown’ genetic risk in a context of rising and
regionally variable cancer incidence, against a background of ‘under-served’ need. At the
same time the biologies that are quite literally mattered in the clinical domain are directly
conﬁgured by inequities in accessing care. This serves to displace some materialities,
including the ‘abject’ cancer body, while bringing others into view. The foregrounding of
the clinical family tree and the convenio in the day to day practices of the clinic are shaped
by the reality of health care inequities, whilst also highlighting the relevance of a relational
biology in assessing risk and pursuing care. For patients, genetic risk is made meaningful
through ideas of bodily vulnerability where emotion and sentiment accumulate as risk
and danger within individual bodies and also, sometimes, across generations. The way
that social relations and affect are constituted by Brazilian patients as embodied danger
reﬂects both a mutability and plasticity in how cancer risk is inferred from, within and
between bodies. Yet these ‘folk’ readings of connected body-selves are also informed by
clinical practice and discourse, including an implicit focus on genetic ancestry. In this way
ideas about a mutable or contingent body informed by emotional vicissitudes of the self
and in relation to others, often across generations, intersect and at times cohere in power-
ful ways with a clinical discourse about genetic risk. While the agentive role of emotions
is mostly foregrounded in patients’ articulations of seemingly ‘porous’ bodies, concerns
about pollution, poor diet, poverty, gendered roles or violence are also sometimes evoked.
Nonetheless these local biologies work mostly to stabilise rather than challenge a biomedi-
cal narrative of genetic risk, despite on-going scientiﬁc contingency about genes and the
risk they constitute vis-a-vis a range of environments. For the moment, patients’ embod-
ied narratives do not themselves directly reveal the wider bio-politics of cancer inequities,
even when as the paper demonstrates, this directly shapes the practices of Brazilian cancer
genetics.
As multiple local biologies become increasingly articulated in the evolving science of
cancer epigenetics across uneven and inequitable terrains of health care, in Brazil and else-
where, it will be important to monitor how and in what ways patients’ understanding of
bodily plasticity and vulnerability are informed by emerging scientiﬁc paradigms and also
shape novel explanations of cancer aetiology. While biomedical narratives of epigenetic
cancer risk are likely to provide a powerfully seductive explanatory frame it will neverthe-
less be vital to monitor the meeting points and intersections between the ensuing differ-
ent, dynamic yet not necessarily disconnected local biologies. At stake is the extent to
which epigenetics facilitates or forecloses a politicisation of health in exposing or silencing
wider social and economic determinants, with consequences for how both individual and
collective responsibility is formulated and acted upon (Lock 2013; Panofsky and Land-
ecker 2013). As such attentiveness to the dynamics by which the biological is being (re)
made in an era of post-genomics creates new opportunities and challenges for anthropo-
logical analysis as intervention. This is particularly when, as this paper illuminates,
anthropological theorisations of the changing biological are taking place alongside and at
the same time as patients, health professionals and scientists are undertaking their own
theorisations.6 Medical anthropology with its history of challenging the idea that bodies
are everywhere the same has much to contribute in ethnographically engaging and
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articulating the theoretical approaches that will prove vital to this task within and far
beyond its sub-disciplinary focus.
Notes
1. Research consisted of observations of clinical encounters and semi-structured interviews with
patients and their families attending three different cancer genetic clinics in urban centres in
the south of Brazil from 2010-2012. Interviews were also undertaken with a range of scientiﬁc
and medical practitioners who were working in the clinical or research environment of cancer
genetics
2. This is indicative of the fact that it is mainly patients’ responsibility in the public health hospi-
tal to store and bring these notes and ﬁles to the clinic.
3. Efforts were sometimes made to pursue a genetic test in this way but were rarely successful.
During the time of my research most private health schemes, which are held by approximately
25% of the population, did not pay for genetic testing. This situation changed in 2013 when
the Brazilian government passed legislation stipulating that certain genetic tests should be cov-
ered by private health insurance schemes.
4. This is a Brazilian expression meaning ‘to swallow your pride’. See Rebhun (1994) for further
discussion.
5. This illness has parallels with other conditions such as susto Mexico (Rubel, O’Nell and
Collado-Ardon 1991).
6. I am grateful to the anonymous reviewer of this paper for highlighting this dimension in their
review.
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